Deepbridge Lifesciences SEIS
A compelling opportunity to invest in a diversified portfolio of companies operating in the life sciences industry, each qualifying for investment under the Seed Enterprise Investment Scheme.
The Deepbridge Life Sciences SEIS provides seed level equity investment into early stage bioscience, pharmaceutical, medical technology and healthcare businesses. Deepbridge seeks to leverage this early stage investment by enabling the investees to use the investment to match against grant and other funding.
Deepbridge adds further value to investee companies by taking a seat on the Board of Directors and using an extensive industry network to access advice and commercial support to the business. Deepbridge also co-invests alongside other early stage investors, including business angels, and act as a feeder to later stage funds.
The Deepbridge Life Sciences SEIS is managed by the Deepbridge Life Sciences Team, which brings together proven experts from the life sciences and business sectors.
The investment objective of the Deepbridge Life Sciences
SEIS is to generate substantial tax-efficient mid-case capital growth of
250pfor every 100p invested, over a minimum 6 year period.
Exit events will be sought at the earliest opportunity after
the third anniversary of the investment made.
Please contact the City Alliance sales team for an application form.
Further further information, or to register your pre-interest to be kept informed about the launch of this SEIS, please contact us on 020 3667 1800 or email email@example.com